Physician profile
Mumtaz Bashir
NPI 1356437883
$4,853.00
in general payments reported to CMS, 2019-2025
16 companies · $722 in 2025
The $722 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $84.94 · 2021: $198 · 2022: $701 · 2023: $1,260 · 2024: $1,672 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,307 · Travel and Lodging: $1,296 · Entertainment: $50.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,306.78 |
| Travel and Lodging | $1,296.17 |
| Entertainment | $50.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,431.22 | 2020-2025 | Misight Contact Lens, Myday Contact Lens, Paragon Crt |
| Bausch & Lomb Americas INC. | $810.57 | 2022-2025 | Infuse, Biotrue One Day |
| Johnson & Johnson Vision Care, INC. | $519.19 | 2019-2022 | |
| Oyster Point Pharma, INC. | $247.51 | 2022-2024 | Tyrvaya |
| Visioneering Technologies, INC. | $177.04 | 2022-2024 | |
| Glaukos Corporation | $144.03 | 2025 | Photrexa Viscous and Photrexa |
| Alcon Vision LLC | $100.34 | 2023-2025 | Eysuvis, Precision7, Simbrinza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $93.77 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $86.71 | 2025 | |
| Dompe US, INC. | $59.33 | 2024-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $54.00 | 2024 | Xdemvy |
| Optos, INC. | $50.76 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $22.80 | 2025 | |
| Kala Pharmaceuticals, INC. | $22.05 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $14.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mumtaz Bashir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.